4//SEC Filing
Erbez Georgia 4
Accession 0001209191-21-011626
CIK 0001708493other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:31 AM ET
Size
9.2 KB
Accession
0001209191-21-011626
Insider Transaction Report
Form 4
Erbez Georgia
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-17$2.12/sh+25,000$53,000→ 72,292 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-02-17−25,000→ 145,908 totalExercise: $2.12Exp: 2028-11-16→ Common Stock (25,000 underlying)
Holdings
- 6,700(indirect: See footnote)
Common Stock
- 8,915(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("David Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by David Erbez IRA Contributory.
- [F2]Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Georgia Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory.
- [F3]The stock option vested and became exercisable as to 25% of the shares subject to the option on October 29, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001557930
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:31 AM ET
- Size
- 9.2 KB